Grace Therapeutics, Inc. (GRCE)
NASDAQ: GRCE · Real-Time Price · USD
2.180
+0.030 (1.40%)
At close: May 20, 2026, 4:00 PM EDT
2.180
0.00 (0.00%)
After-hours: May 20, 2026, 4:10 PM EDT
Grace Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
6
Market Cap
33.73M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | - | - | - |
| Mar 31, 2024 | - | - | - |
| Mar 31, 2023 | - | - | - |
| Mar 31, 2022 | - | - | - |
| Mar 31, 2021 | 196.00K | - | - |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 29, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Veru Inc. | 16.89M |
| Apollomics | 8.84M |
| Evaxion | 7.53M |
| Aligos Therapeutics | 4.71M |
| RenovoRx | 1.49M |
| Pluri | 1.08M |
| Actinium Pharmaceuticals | 90.00K |
GRCE News
- 8 days ago - Largest borrow rate increases among liquid names - TheFly
- 26 days ago - Grace Therapeutics price target lowered to $4 from $11 at Craig-Hallum - TheFly
- 26 days ago - Grace Therapeutics price target lowered to $8 from $12 at TD Cowen - TheFly
- 27 days ago - Grace Therapeutics down 48% after receipt of CRL from FDA for GTx-104 - TheFly
- 27 days ago - Grace Therapeutics, Inc trading resumes - TheFly
- 27 days ago - US FDA declines to approve Grace Therapeutics' drug for a type of stroke - Reuters
- 27 days ago - Grace Therapeutics issued Complete Response Letter from FDA - TheFly
- 27 days ago - Grace Therapeutics Provides Regulatory Update on New Drug Application for GTx-104 - GlobeNewsWire